Skip to content

Geriatrics & Palliative Medicine Funding: Addition to Primary List

Drug Development Program

Alzheimer's Drug Discovery Foundation

3-Feb-25

$5,000,000USD

Integrative Research to Understand the Impact of Sex Differences on the Molecular Determinants of AD Risk and Responsiveness to Treatment (U01 Clinical Trial Optional)

National Institute on Aging (NIA)

National Institutes of Health (NIH)

21-Feb-25

Leave a Reply

Your email address will not be published. Required fields are marked *